Veos Pharmaceuticals, SL
SME
www.veospharma.comMadrid, SpainAbout
Veos Pharmaceuticals is a science-driven biotech company developing clinically validated, natural health solutions for aging, performance, metabolism, and immunity.
Our pipeline includes:
-
ThymoTropin™ – the world’s first natural myostatin-regulating ingredient for muscle health, sarcopenia, and GLP-1-associated muscle loss.
-
StroVia™ – a natural metabolism and strength-enhancing formula now commercially launched in Canada.
-
OliQuell™ – a patented olive-waste-based functional platform for air purification and circular economy applications.
-
BioPropello™ – a biostimulant improving protein synthesis and stress resilience in agriculture.
Veos is GMP-compliant, IP-driven, and regulatory-ready, with active approvals under GRAS, EFSA, and Health Canada. Our business model is B2B licensing, partnering with global leaders in consumer health, pharma, and food.
We are operational in North America, the EU, and expanding into Asia through strategic alliances